Introduction
Alteration of chromatin is central to genomic regulation. Chromatin is composed of nucleosomes which are particles consisting of DNA in association with an octamer of two molecules each of the core histone proteins (H2A, H2B, H3 and H4) as well as the linker histone H1. Alterations in chromatin structure modulate the expression of underlying genes; transcriptional induction or repression typically requires chromatin remodeling. One type of alteration is covalent modi®cation of the end of histones, and in particular, the amino termini of the core histones, which extend from the nucleosome, and may interact with neighboring nucleosomes (Luger et al., 1997) . The last 5 years has witnessed a remarkable expansion of research in this area, owing largely to the contemporaneous discoveries of the ®rst nuclear histone acetyltransferase as a coactivator of transcription and the ®rst histone deacetylase as a corepressor of transcription (Taunton et al., 1996) . These discoveries have been followed by investigations into mechanism and eects of acetylation, and signi®cantly, identi®cation of other covalent modi®ca-tions including phosphorylation, methylation and ubiquitination, as regulators of transcription. This review focuses on recent studies of histone covalent modi®cations. The array of such modi®ca-tions will be discussed and the identity of the enzymes responsible, as this has been revealing of the biological role of the modi®cations. Summaries of the current knowledge of the modi®cation sites and enzymes responsible are presented (Tables 1 and 2) . Recent evidence that acetylation of histones and factors acts positively or negatively in concert with other modi®cations are discussed. Finally, data investigating the mechanisms of these modi®cations are reviewed.
Modi®cations of histones

Acetylation
Acetylation is the best characterized of the covalent modi®cations of histones as it was the ®rst to be discovered. There are many current detailed reviews of acetylation of histones and factors (e.g. Cheung et al., 2000b; Brown et al., 2000; Sterner and Berger, 2000) and therefore this review presents the current most widely accepted model for acetylation and then summarizes recent salient ®ndings without great detail. In general, studies of acetylation have led the way in understanding the occurrence of modi®cations, the enzymes that catalyze them, and has generated overarching models of how all types of histone modi®ca-tions may function to alter gene expression.
The general model ( Figure 1 ) that has emerged for the role of acetylation derives from the initial observations that the histone acetyltransferases (HAT) enzymes are transcriptional coactivators, such as yeast Gcn5, mammalian CBP/p300 and Taf II 250 . Models for coactivator function that predated the discovery of HAT activity, proposed that they are brought to promoters by interaction with DNA-bound activators (Figure 1c) , resulting in recruitment of the general transcriptional apparatus (Figure 1d ). The model was simply elaborated to include the enzymatic acetylation activity (Figure 1c ) which directs disruption of the chromatin around the promoter , and has been largely corroborated over the last 5 years (Cheung et al., 2000b; Brown et al., 2000; Sterner and Berger, 2000) , as described below.
Some of the mechanisms ascribed to acetylation have not yet been investigated for the other modi®cations, but are likely to be highly pertinent to their function as well. As mentioned above, the ®rst identi®ed HATs were previously known transcriptional coactivators or adaptors, and others previously unknown, were discovered in the context of transcription. Acetyltransferases occur in large complexes containing many subunits (Grant et al., 1997; Allard et al., 1999) . These additional subunits provide essential functions, such as interaction with DNA-bound activators for targeting to speci®c promoters (Utley et al., 1998) , recruitment of basal factors (Sterner et al., 1999) , establishment of substrate speci®city such as to speci®c lysine residues, speci®c histones and to nucleosomes (Kraus et al., 1999; Kuo et al., 1996; Sterner et al., 1999) , as well as other regulatory activities Dudley et al., 1999) . The crystal structure has been determined for a HAT enzyme from one complex bound to its histone substrate, providing insight into catalytic mechanism of histone acetylation (Rojas et al., 1999) . The complexes work in concert with the other major type of chromatin altering activity, the ATP-dependent nucleosome remodeling complexes, typi®ed by yeast Swi/Snf (Sudarsanam and Winston, 2000) . Recent studies have revealed that ®rst, each type of complex is recruited to promoters in a sequence that is characteristic of that promoter and second, extensive functional interactions occur between these complexes (Krebs et al., 2000; Cosma et al., 1999; Syntichaki et al., 2000) . Finally, the extent of the acetylated domain within several promoters has been mapped and found to be fairly local ± one or two nucleosomes (Kuo et al., 1998; Rundlett et al., 1998; Kadosh and Struhl, 1998) , although this gene-speci®c acetylation is superimposed upon a more global acetylation level who function is mysterious (Vogelauer et al., 2000; Zhang et al., 1998; Krebs et al., 1999; Berger, 2000) .
In addition to histones, transcription activators are themselves a majore substrate of the acetyltransferases, including well-known activators such as p53 . Current date indicates that acetylation of transcription factors alters their binding anity to DNA (Gu and Roeder, 1997) , although other eects, such as increased stability, have also been detected (Kouzarides, 2000) . Interestingly, evidence was recently obtained for acetylation of a nontranscription factor, one of the nuclear pore components (Bannister et al., 2000) . Thus, an emerging view is that acetylation is a general modi®cation used widely for signal transduction and gene regulation, much like phosphorylation (Kouzarides, 2000) .
In addition to the well-known coactivators that are acetyltransferases, the ®rst DNA-bound acetyltransferase was identi®ed, ATF-2, a transcriptional activator (Kawasaki et al., 2000) . The signi®cance of this is that histone acetylation activity is brought directly to the promoter within a sequence-speci®c binding factor itself, without recruitment of the enzyme in the form of a coactivator. It is clear that this scenario removes a possible regulatory step, i.e. activator interaction with a coactivator/acetyltransferase. It is not known whether this strategy is general, as there have been no further reports of enzymatic activity in DNA-bound activators.
Phosphorylation
It is now becoming clear that histone phosphorylation is an important regulatory mechanism both during cell division, to condense chromosomes during mitosis and meiosis, and to regulate transcriptional activation. The signi®cance of the ®nding that phosphorylation occurs in such apparently dierent genomic activities (i.e. contraction of the chromatin structure during mitosis vs expansion during gene expression) is discussed in a later section.
Several studies have indicated that histone H3 phosphorylation on serine 10 and serine 28 correlates with mitotic chromosome condensation (Van Hooser et al., 1998; de la Barre et al., 2000; Goto et al., 1999; Sauve et al., 1999) . The role of histone phosphorylation during the cell cycle was clearly established in Tetrahymena, where mitosis is restricted to the germ line micronuclei, and transcription is limited to the amitotic macronuclei. A mutation of histone H3 serine 10 to alanine caused abnormal condensation, segregation and loss of chromosomes, demonstrating that phosphorylation has a critical role in micronuclear mitotic cell division (Wei et al., 1999) . Two classes of kinases, previously known to be required for chromosome condensation, were recently shown to phosphorylate histone H3 serine 10 during the cell cycle. In Aspergillus nidulans, the NIMA kinase phosphorylates serine 10 in vitro, and is required for H3 phosphorylation in vivo (De Souza et al., 2000) . In yeast and C. elegans, the Ipl1/Aurora kinase family, and the opposing Glc7/PP1 phosphatases, were shown by mutational analysis to establish the level of mitotic serine 10 phosphorylation . It is not yet clear how phosphorylation actually generates the condensed chromatin structure.
Histone pohsphorylation also has a role in transcriptional activation, both in mammalian cells and in yeast. Growth factor-stimulated mammalian cells turn on a set of immediate early genes, including c-fos and c-jun and histone H3 phosphorylation shows a correlative increase (Mahadevan et al., 1991) , which has recently been demonstrated to occur on serine 10 (Sassone- Corsi et al., 1999) . Recently there have been several additional reports of a role of phosphorylation in gene activation. In yeast, certain genes regulated by the acetyltransferase Gcn5 are also regulated by phosphorylation of serine 10 of histone H3 (Lo et al., 2000) , and second, in D. melanogaster, the heat shock genes are regulated by phosphorylation of the same residue (Nowak and Corces, 2000) . Finally, the mammalian circadian clock may be controlled in part by lightinduced phosphorylation of histone H3 serine 10 in neuronal cells of the hypothalamus (Crosio et al., 2000) It is noteworthy, but not yet understood, that serine 10 is the common target of kinases that regulate both mitosis and gene expression.
The kinases that carry out histone H3 phosphorylation of serine 10 in the mammalian growth factor response have been identi®ed. One study identi®ed Rsk-2 (Sassone-Corsi et al., 1999) and a second study identi®ed Msk1 (Thomson et al., 1999) as mitogenstimulated, histone H3 serine 10 kinases. Interestingly, mutations in Rsk2 causing a loss of histone H3 phosphorylation may be the direct cause of Con ± Lowry syndrome in humans, a profound genetic disease (Sassone-Corsi et al., 1999) . Overall, it is unknown whether there are a large number of kinases that target histones as substrates.
Methylation
Investigations of histone methylation have recently implicated this modi®cation in gene activation and heterochromatic DNA silencing. Methylation can occur on both arginine and lysine residues, and putative enzymes that perform each of these modi®ca-tions have recently been identi®ed.
A coactivator of transcription activated by nuclear hormone receptors in mammalian cells is CARM1, a relative to PRMT1 (Chen et al., 1999) . Both are histone arginine methyltransferases; CARM1 primarily targets histone H3, while PMRT1 primarily targets histone H4. CARM1's coactivator function requires its enzymatic activity (Chen et al., 1999) , and in transfection assays the two function synergistically to induce transcription (Koh et al., 2001) . These enzymes target other proteins and it is not known whether histones are a primary substrate in vivo.
Histone lysine methylation has been shown to occur in Tetrahymena macronuclei, which is devoted to transcription, but not within micronuclei, which are germ line (Strahl et al., 1999) . This methylation occurs on lysine 4 of histone H3, a novel target site conserved from yeast to mammals, but a function for this modi®cation has not yet been demonstrated. Recently the ®rst lysine methyltransferase enzyme was identi®ed (Rea et al., 2000) as a gene previously known to function in heterochromatic silencing in D. melanogaster, Su(var)39 (Suppressor of variegation 39). Su(var)39 methylates primarily lysine 9 of histone H3. Interestingly, the enzymatic domain in Su(var)39 is within its SET domain, which is a highly conserved region present in many proteins throughout eukaryotes, suggesting that lysine methylation, like acetylation and phosphorylation, may be a common regulatory modi®cation.
Ubiquitination
Two recent reports describe ubiquitination as another important modi®cation of histones. Previous analyses in mammalian cells indicated that ubiquitination of the carboxyl terminus of H2A is prevalent. Analysis of putative ubiquitination sites in both H2A and H2B in yeast revealed that sites in H2B were critical for mitotic and meiotic cell cycle progression (Robzyk et al., 2000) . Ubiquitinated H2B was detected in vivo, and Rad6 was identi®ed as the major cellular enzyme. The coactivator and acetyltransferase Taf II 250 was identi®ed as an histone H1 ubiquitin-conjugating enzyme (Pham and Sauer, 2000) . Mutations that lower Taf II 250's ubiquitin-conjugating activity in vitro, but not its acetyltransferase activity, reduced Taf II 250's coactivator activity in D. melanogaster. Remarkably, Taf II 250 has three reported enzymatic activities: acetyltransferase (candidate substrates are core histones; Mizzen and Allis, 2000), kinase (one candidate substrate is the basal transcription factor TFIIA; Solow et al., 2000) , and ubiquitin-conjugation (candidate substrate is linker histone H1). These studies implicate ubiquitination as an important regulatory mechanism of transcription, similar to acetylation, phosphorylation and methylation. Summaries of the various modi®cations and enzymes are presented in Tables 1 and 2 .
Combined modi®cations
As indicated by the section above, there is evidence for a wide variety of histone modi®cations. Why do so many modi®cations exist? One possibility is that the modi®cations may occur together in the same histone tails, and may cross in¯uence one another. In the past year evidence has emerged that there is indeed crosstalk between modi®cations.
Acetylation/phosphorylation
It appears that acetylation is used in conjunction with phosphorylation in both histone and transcription factor substrates. In both cases phosphorylation appears to occur prior to, and appears to promote, acetylation.
In the case of histones, phosphorylation of histone H3 at serine 10 results in a higher level of enzymatic activity by the acetyltransferase Gcn5 on the neighboring lysine 14 (Lo et al., 2000; Cheung et al., 2000a) . This may result from stabilization of binding of the phosphorylated substrate. One particular mutation in Gcn5, at a putative contact point with the phosphorylated substrate, speci®cally lowered acetylation on a phosphorylated H3 substrate but not an unmodi®ed substrate. In vivo evidence also suggested that phosphorylation promotes acetylation. In yeast, the mutation in Gcn5 that lowered activity in vitro on the phosphorylated substrate, reduced transcription at a subset of Gcn5-dependent promoters, and mutation of serine 10 to alanine in histone H3 also reduced activity at these same promoters (Lo et al., 2000) . In mammalian cells, following stimulation of arrested cells with growth factors, immediate gene transcription, such as c-fos/cjun, is turned on, and histone H3 phosphorylation at serine 10 occurs quickly, followed by acetylation of lysine 14 on the subfraction of phosphorylated histone H3 (Cheung et al., 2000a) . A separate study showed a correlation, but not sequential dependence, of phosphorylation at serine 10 and acetylation at lysine 9 in histone H3 associated with the c-fos/c-jun promoters (Clayton et al., 2000) . The ®ndings that phosphorylation and acetylation are both required for transcriptional activation, and that acetylation is promoted by prior phosphorylation, leads to the model depicted in Figure 1 , where an activator targets sequential histone kinase and acetylation activities to a promoter.
As discussed above, acetylation is not limited to histones, but also occurs on other proteins. The relationship between phosphorylation and acetylation applies here as well. For example, phosphorylation of p53 precedes and promotes acetylation (Chao et al., 2000; Sakaguchi et al., 1998) . In this case, in contrast to histones, the phosphorylation is quite distant from the acetylation sites, since acetylation occurs at the C terminus at lysine residues 320, 373, and 382, while phosphorylation occurs at the N terminus within the activation domain, at residues 33, 37 (Sakaguchi et al., 1998) . Thus, in the p53 case, phosphorylation is not likely to be promoting acetylation by improving enzyme interaction with the substrate active site, but rather may be helping to recruit acetylation complexes through direct interaction, which would then result in the acetyltransferase gaining access to both p53 and histones.
Acetylation/methylation
As yet there are no detailed studies on interactions of acetylation and methylation, but there is some evidence for both positive and negative cross-in¯uences of these modi®cations. In Tetrahymena, where lysine 4 has been seen to be methylated in the transcriptionally-active macronuclei, as described above, the methylation appears to be coincident with an acetylated subpopulation of histone H3 (Strahl et al., 1999) . On its face, this suggests that lysine 4 methylation may be stimulatory to transcription, since acetylation of H3 has largely correlated with activation.
As described above, the lysine methyltransferase Su(var)39 methylates lysine 9 in histone H3 and is required for heterochromatic silencing. Lysine 9 is adjacent to serine 10 and is near lysine 14, the sites of transcriptional stimulatory phosphorylation and acetyl-ation, respectively. It therefore is reasonable that lysine 9 methylation inhibits kinase activity at serine 10, and the opposite is true also, that serine 10 phosphorylation inhibits methylation at lysine 9 (Rea et al., 2000) .
Mechanism of modi®cations
There are two current models for the function of modi®cations. One is that the modi®cations directly aect structure of chromatin or nucleosomes, and the second is that the modi®cations serve as a site for recruiting other proteins. That multiple modi®cations exist and are synergistic can be accomodated by either model, and neither is exclusive of the other.
Electrostatic changes may alter the mutual interaction of nucleosomes in arrays, allowing opening or closing of the structure, or may alter the interaction of the core histones with DNA in nucleosomes (Annunziato and Hansen, 2000) . This would allow increased accessibility of transcription factors to the chromatin. In terms of causing changes in chromatin structure, both acetylation and phosphorylation alter charge in the same direction, causing a loss of positivity in the histone tails.
The second hypothesis for the role of modi®cations is that they constitute patterns in the histone tails for interactions with speci®c factors that may achieve function. This idea has been recently described in details, and referred to as the`histone code' hypothesis . Examples of such interactions already exist. For example, transcriptional activation involves acetylation of histones H3 and H4. Chromatin altering proteins, including HATs, are often associated with speci®c protein domains, called bromodomains and chromodomains. Interestingly, the bromodomains in PCAF (a Gcn5 homologue) (Dhalluin et al., 1999) , and in Taf II 250 (Pham and Sauer, 2000) promote interaction with acetylated histones (Figure 2b and d) . Another important example is the chromodomain of the heterochromatic protein HP1, which interacts with methyl-Lys 9 of histone H3 (Bannister et al., 2001 ; Figure 2c ), the residue targeted by the methyltransferase Su(var)39 (Rea et al., 2000) , as described above. Finally, gene repression is associated with hypoacetylation of histone tails, and the yeast Tup1/Ssn6 repressor complex preferentially associates with underacetylated histones H3 and H4  Figure  2a) . Thus, there are now several signi®cant examples of factors binding to histone tails bearing speci®c modi®cations.
Perspectives and future directions
Three remain many questions about the incidence, role and regulation of histone modi®cations and the enzymes that catalyze them. As described above, much is known about acetyltransferases, such as the size and components of their multisubunit complexes, speci®city of modi®cation, recruitment to speci®c promoters, and interaction with basal transcription factors. However, little is known about kinases, methyltransferases or ubiquitin-conjugation enzymes. Some of these enzymes may be monomeric and may not be speci®cally recruited, while others may be recruited via activator interactions, similar to the HATs.
For multiple modi®cations there are a number of interesting questions. First, how extensive are the modi®cations? This is known only partially for the HATs, and only very limited knowledge exists for the kinases, methytransferases and ubiquitin-conjugating enzymes. Are intricate patterns of modi®cations typical, and are there combinations between the dierent types of modi®cations? Are changes in the level of enzymatic activity the normal case, as observed for the eect of phosphorylation on Gcn5's acetylation activity? Since Taf II 250 possesses both histone acetylation and ubiquitination activity, it is reasonable to investigate whether many of the multisubunit complexes have multiple enzymatic activities. These questions, and the many additional questions to be answered in the future, give a small indication of the discoveries that await in the fascinating ®eld of chromatin regulation. 
